<!DOCTYPE html>
<html>

  <head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <title>Edx-biomanufacturing学习笔记</title>
  <meta name="description" content="Table of Content">

  <link rel="stylesheet" href="/css/main.css">
  <link rel="canonical" href="http://localhost:4000/2015/09/14/MITx_biomanufacturing.html">
  <link rel="alternate" type="application/rss+xml" title="Huanwei Wang's blog" href="http://localhost:4000/feed.xml">
</head>


  <body>

    <!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-121065275-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-121065275-1');
</script>



    <header class="site-header">

  <div class="wrapper">

    <a class="site-title" href="/">Huanwei Wang's blog</a>

    <nav class="site-nav">
      <a href="#" class="menu-icon">
        <svg viewBox="0 0 18 15">
          <path fill="#424242" d="M18,1.484c0,0.82-0.665,1.484-1.484,1.484H1.484C0.665,2.969,0,2.304,0,1.484l0,0C0,0.665,0.665,0,1.484,0 h15.031C17.335,0,18,0.665,18,1.484L18,1.484z"/>
          <path fill="#424242" d="M18,7.516C18,8.335,17.335,9,16.516,9H1.484C0.665,9,0,8.335,0,7.516l0,0c0-0.82,0.665-1.484,1.484-1.484 h15.031C17.335,6.031,18,6.696,18,7.516L18,7.516z"/>
          <path fill="#424242" d="M18,13.516C18,14.335,17.335,15,16.516,15H1.484C0.665,15,0,14.335,0,13.516l0,0 c0-0.82,0.665-1.484,1.484-1.484h15.031C17.335,12.031,18,12.696,18,13.516L18,13.516z"/>
        </svg>
      </a>

      <div class="trigger">
        
          
        
          
          <a class="page-link" href="/about/">About</a>
          
        
          
        
          
        
          
        
          
        
          
        
          
          <a class="page-link" href="/links/">Links</a>
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
          <a class="page-link" href="/tags/">Tags</a>
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
      </div>
    </nav>

  </div>

</header>


    <div class="page-content">
      <div class="wrapper">
        <article class="post" itemscope itemtype="http://schema.org/BlogPosting">

  <header class="post-header">
    <h1 class="post-title" itemprop="name headline">Edx-biomanufacturing学习笔记</h1>
    <p class="post-meta"><time datetime="2015-09-14T00:00:00+10:00" itemprop="datePublished">Sep 14, 2015</time></p>
  </header>

  <div class="post-content" itemprop="articleBody">
    <h2 id="table-of-content">Table of Content</h2>

<ul>
  <li><a href="#unit1">Unit 1 Introduction</a></li>
  <li><a href="#unit2">Unit 2 Protein Structure and Examples</a></li>
</ul>

<h1 id="-unit-1-introduction"><a name="unit1"></a> Unit 1 Introduction#</h1>

<h2 id="section-1-introduction">Section 1 Introduction##</h2>

<h3 id="11a-why-biologic-drugs-are-important">1.1A Why Biologic Drugs are important?###</h3>

<h3 id="11b-what-to-expect-for-the-course">1.1B What to expect for the course</h3>

<h3 id="12-what-are-biologic-drugs">1.2 What are biologic drugs?</h3>

<p>In the FDA definition, biologic drugs: Proteins, Vaccines, Blood components, Cell therapies, Natural hormones, Pland/animal extracts</p>

<p>Biologics manufactured using recombinant DNA technology: Replace missing function, Selective, Fewer off-target effects</p>

<h2 id="section-2-using-cells-for-manufacturing">Section 2 Using Cells for manufacturing</h2>

<p>###1.3 An introduction to the history of modern biomanufacturing</p>

<p><img src="/images/1441869699042.png" alt="timeline" /></p>

<p>1675, Antonie van Leeuwenhoek, Netherlands, mciroscope</p>

<p>1850, Louis Pasteur, France, alcoholic fermentation (yeast: alcohol; bacteria: lactic acid)</p>

<h3 id="14-using-cells-to-manufacture-chemicals">1.4 USING CELLS TO MANUFACTURE CHEMICALS</h3>

<p>1915, Wilhelm Connstein and Karl Ludecke, together with Carl Alexander Neuberg and Elsa Reinfurth, German, used yeast to manufacture glycerol (甘油).</p>

<p>1904, Chaim Weizmann, UK,  isolated the bacterium, Clostridium acetobutylicum, which could ferment grain to produce butanol (丁醇).</p>

<p>(Cell manufacture chemicals; Aseptic processing = better control)</p>

<h3 id="15-using-cells-to-manufacture-penicillin-and-vaccines">1.5 USING CELLS TO MANUFACTURE PENICILLIN AND VACCINES</h3>

<p>1928, Alexander Fleming, London, identified penicillin, which killed or prevented the growth of a number of different bacterial species.</p>

<p>1939, Howard Florey and Ernst Boris Chain succeeded in isolating penicillin.</p>

<p>1957, Jonas Salk,  the production of the polio (骨髓灰质炎) vaccine was the first time mammalian cells were used in manufacturing.</p>

<p>(First, aseptic processing provides better control of the culture and its products.)</p>

<p>(Second, microorganisms can produce safe and effective drugs.)</p>

<p>(Third, genetic mutation and selection can be used to improve cellular productivity.)</p>

<p>(And fourth, mammalian cells can produce therapeutics.)</p>

<p>##Section 3 Protein as therapeutics</p>

<p>###1.6 THE HISTORY OF PROTEINS AS THERAPEUTICS: ANTI-TOXINS</p>

<p>1894, Emil von Behring, German, invented the diphtheria (白喉) anti-toxin</p>

<h3 id="17-the-discovery-and-isolation-of-insulin">1.7 THE DISCOVERY AND ISOLATION OF INSULIN</h3>

<p>1989, Oscar Minkowski and Joseph von Mering found unknown substance in the pancreas, which we now know is insulin, was responsible for regulating sugar levels in the body</p>

<p>1920, Frederick Grant Banting and Charles Herbert Best extracted what they hoped was insulin from the pancreas of dogs</p>

<p>(Challenges: 1. Different sequence; 2. Supply)</p>

<h3 id="18-isolation-of-protein-therapeutics-from-plasma">1.8 ISOLATION OF PROTEIN THERAPEUTICS FROM PLASMA</h3>

<p>1940, Edwin J. Cohn, began to work on isolating Albumin (白蛋白) from blood plasma through a process called fractionation.</p>

<p>1970s, factor III replaced albumin as the most profitable product in the plasma fractionation industry.</p>

<p>(Challenges: 1. Supply; 2. Contamination)</p>

<p>##Section 4 Intro to modern biomanufacturing</p>

<h3 id="19-the-birth-of-modern-biomanufacturing">1.9 THE BIRTH OF MODERN BIOMANUFACTURING</h3>

<p>1973, the recombinant DNA technology</p>

<p>1979 ~ 1981, Genzyme (beta-glucoserebrosidase purified from human placenta, Ceredase, Cerezyme), Genentech (first human insulin produced using recombinant DNA technology)</p>

<p>###1.10 BIOMANUFACTURING IS THE VEHICLE TO DELIVER HIGH-QUALITY BIOLOGICS</p>

<p><img src="/images/1441870976573.png" alt="Alt text" /></p>

<h1 id="-unit-2-protein-structure--examples"><a name="unit2"></a> Unit 2 Protein Structure &amp; Examples</h1>

<h2 id="section-1-introduction-to-protein-structure">Section 1 Introduction to Protein Structure</h2>

<h3 id="21-introduction-to-biologic-drugs">2.1 Introduction to biologic drugs</h3>

<table>
  <thead>
    <tr>
      <th style="text-align: left">small molecules</th>
      <th style="text-align: right">Recombinant biologics</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="text-align: left">Aspirin, Penicillin, Ibuprofen</td>
      <td style="text-align: right">MAb (e.g. Rituximab), insulin</td>
    </tr>
    <tr>
      <td style="text-align: left">100 - 900 Da</td>
      <td style="text-align: right">5,000 - 250,000 Da</td>
    </tr>
    <tr>
      <td style="text-align: left">Chemical systhesis</td>
      <td style="text-align: right">Cellular synthesis</td>
    </tr>
    <tr>
      <td style="text-align: left">Simple analysis</td>
      <td style="text-align: right">Complex analysis</td>
    </tr>
    <tr>
      <td style="text-align: left">absorbed through GI tract</td>
      <td style="text-align: right">parenteral: bypass GI tract</td>
    </tr>
    <tr>
      <td style="text-align: left">mimic compounds; block pathways; unintended interatcions</td>
      <td style="text-align: right">specific; few off-target effects</td>
    </tr>
  </tbody>
</table>

<ul>
  <li>Drug targets:
    <ol>
      <li>Receptor proteins;</li>
      <li>DNA;</li>
      <li>RNA</li>
    </ol>
  </li>
  <li>Reduce biologic effectiveness:
    <ol>
      <li>misfolding;</li>
      <li>aggregate</li>
    </ol>
  </li>
  <li>Parenteral (不经肠的):
    <ol>
      <li>intravenous (静脉) injection;</li>
      <li>intramuscular (肌肉) injection;</li>
      <li>subcutaneous (皮下) injection;</li>
      <li>inhalation (吸入);</li>
      <li>mucosal (粘膜) transmission</li>
    </ol>
  </li>
  <li>Categories of biotherapeutics:
    <ol>
      <li>Enzymatic or regulatory activity (<em>e.g.</em> Insulin; Imiglucerase for Gaucher’s disease; Erythropoietin for stimulating production of  RBCs and anemia (贫血));</li>
      <li>Special targeting activity (<em>e.g.</em> Rituximab for B-cell non-Hodgkin’s lymphomas (淋巴瘤));</li>
      <li>Protein vaccines (<em>e.g.</em> Hepatitis (肝炎) B; Influenza (流感); Human papillomavirus)</li>
    </ol>
  </li>
</ul>

<p>###2.2 Introduction to amino acids</p>
<ul>
  <li>20 amino acids
    <ol>
      <li>Polar, Uncharged: Serine (Ser, S); Threonine (Thr, T); Asparagine (Asn, N); Glutamine (Gln, Q)</li>
      <li>Polar, negatively charged: Aspartic acide (Asp, D); Glutamic acid (Gln, Q)</li>
      <li>Polar, positively charged: Lysinee (Lys, K); Arginine (Arg, R); Histidine (His, H)</li>
      <li>Hydrophobic: Alanine (Ala, A); Valine (Val, V); Methionine (Met, M); Leucine (Leu, L); Isoleucine (Ile, I); Phenylalanine (Phe, F); Tyrosine (Tyr, Y); Tryptophan (Try, W)</li>
      <li>Special: Glycine (Gly, G); Cysteine (Cys, C); Proline (Pro, P)
|Peptides|Proteins|
| :——– | ——–:|
|&lt;= 40 amino acids| &gt; 40 amino acids|</li>
    </ol>
  </li>
</ul>

<p>###2.3 Introduction to Protein Structure</p>
<ul>
  <li>Protein Structure:
    <ol>
      <li>Primary structure: the amino acid sequence</li>
      <li>Secondary structure: interactions among backbone atoms (α-helix, β-sheet, loop) (hydrogen bone between backbones)</li>
      <li>Tertiary structure: interactions among all atoms in 3D space (bisulfide bonds of cysteines, electrostatic interactions - ionic bonds bewteen opposite charges, hydrogen bone between threonine with water, hydrophobic interactions)</li>
      <li>Quaternary structure: arrangement of multiple protein subunits (monomer, dimer, hexamer)</li>
    </ol>
  </li>
</ul>

<p>###2.4 Post translational modifications (PTMs)</p>
<ul>
  <li>Types of PTMs:
    <ol>
      <li>Glycosylation (糖基化)</li>
      <li>Deamidation (脱酰胺)</li>
      <li>Oxidation</li>
      <li>Acylation (乙酰化)</li>
      <li>PEGylation (PEG, Polyethylene Glycol, 聚乙二醇)</li>
    </ol>
  </li>
</ul>

<p>Notes for the <a href="https://www.edx.org/">edx</a> course <a href="https://www.edx.org/course/making-biologic-medicines-patients-mitx-10-03x">Making Biologic Medicines for Patients: The Principles of Biopharmaceutical Manufacturing</a></p>

  </div>

</article>

      </div>
    </div>

    <footer class="site-footer">

  <div class="wrapper">


    <div class="footer-col-wrapper">
      <div class="footer-col footer-col-1">
        <ul class="contact-list">
          <li>Huanwei Wang's blog</li>
          <li><a href="mailto:zju_whw@163.com">zju_whw@163.com</a></li>
        </ul>
      </div>

      <div class="footer-col footer-col-2">
        <ul class="social-media-list">
          
          <li>
            <a href="https://github.com/zjuwhw"><span class="icon icon--github"><svg viewBox="0 0 16 16"><path fill="#828282" d="M7.999,0.431c-4.285,0-7.76,3.474-7.76,7.761 c0,3.428,2.223,6.337,5.307,7.363c0.388,0.071,0.53-0.168,0.53-0.374c0-0.184-0.007-0.672-0.01-1.32 c-2.159,0.469-2.614-1.04-2.614-1.04c-0.353-0.896-0.862-1.135-0.862-1.135c-0.705-0.481,0.053-0.472,0.053-0.472 c0.779,0.055,1.189,0.8,1.189,0.8c0.692,1.186,1.816,0.843,2.258,0.645c0.071-0.502,0.271-0.843,0.493-1.037 C4.86,11.425,3.049,10.76,3.049,7.786c0-0.847,0.302-1.54,0.799-2.082C3.768,5.507,3.501,4.718,3.924,3.65 c0,0,0.652-0.209,2.134,0.796C6.677,4.273,7.34,4.187,8,4.184c0.659,0.003,1.323,0.089,1.943,0.261 c1.482-1.004,2.132-0.796,2.132-0.796c0.423,1.068,0.157,1.857,0.077,2.054c0.497,0.542,0.798,1.235,0.798,2.082 c0,2.981-1.814,3.637-3.543,3.829c0.279,0.24,0.527,0.713,0.527,1.437c0,1.037-0.01,1.874-0.01,2.129 c0,0.208,0.14,0.449,0.534,0.373c3.081-1.028,5.302-3.935,5.302-7.362C15.76,3.906,12.285,0.431,7.999,0.431z"/></svg>
</span><span class="username">zjuwhw</span></a>

          </li>
          

          
          <li>
            <a href="https://twitter.com/huanwei_wang"><span class="icon icon--twitter"><svg viewBox="0 0 16 16"><path fill="#828282" d="M15.969,3.058c-0.586,0.26-1.217,0.436-1.878,0.515c0.675-0.405,1.194-1.045,1.438-1.809c-0.632,0.375-1.332,0.647-2.076,0.793c-0.596-0.636-1.446-1.033-2.387-1.033c-1.806,0-3.27,1.464-3.27,3.27 c0,0.256,0.029,0.506,0.085,0.745C5.163,5.404,2.753,4.102,1.14,2.124C0.859,2.607,0.698,3.168,0.698,3.767 c0,1.134,0.577,2.135,1.455,2.722C1.616,6.472,1.112,6.325,0.671,6.08c0,0.014,0,0.027,0,0.041c0,1.584,1.127,2.906,2.623,3.206 C3.02,9.402,2.731,9.442,2.433,9.442c-0.211,0-0.416-0.021-0.615-0.059c0.416,1.299,1.624,2.245,3.055,2.271 c-1.119,0.877-2.529,1.4-4.061,1.4c-0.264,0-0.524-0.015-0.78-0.046c1.447,0.928,3.166,1.469,5.013,1.469 c6.015,0,9.304-4.983,9.304-9.304c0-0.142-0.003-0.283-0.009-0.423C14.976,4.29,15.531,3.714,15.969,3.058z"/></svg>
</span><span class="username">huanwei_wang</span></a>

          </li>
          
        </ul>
      </div>

      <div class="footer-col footer-col-3">
        <p>This is Huanwei Wang's personal blog. Powered by Jekyll and Host in Github.
</p>
      </div>
    </div>

  </div>

</footer>


  </body>

</html>
<script type="text/x-mathjax-config">
MathJax.Hub.Config({
  tex2jax: {
    inlineMath: [['$','$'], ['\\(','\\)']],
    processEscapes: true
  }
});
</script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js?config=TeX-AMS-MML_HTMLorMML" type="text/javascript"></script>
